Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.47 |
| ▸ | KDM1A | O60341 | 4/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
| ▸ | FNTB | P49356 | 1/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 2/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.34 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.34 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21931742 | 0.94 | KIF11 (0.42) | KIF11KDM1ACHEK1CYP19A1FNTA | |
| SCHEMBL21929232 | 0.91 | KIF11 (0.48) | KIF11KDM1ACHEK1CYP19A1FNTA | |
| SCHEMBL21929224 | 0.89 | KIF11 (0.43) | KIF11KDM1ACYP19A1FNTAFNTB | |
| SCHEMBL21928456 | 0.88 | KIF11 (0.47) | KIF11CYP19A1CYP11B2 | |
| SCHEMBL21929019 | 0.87 | MAT2A (0.38) | KIF11CYP11B2SLC22A12 | |
| SCHEMBL21928442 | 0.86 | CHEK1 (0.38) | KDM1ACHEK1ARCYP11B2SLC22A12 | |
| SCHEMBL21928639 | 0.84 | CHEK1 (0.45) | KIF11CHEK1ARCYP11B2SLC22A12 | |
| SCHEMBL23348414 | 0.84 | KIF11 (0.46) | KIF11KDM1ACHEK1CYP19A1 | |
| SCHEMBL21931740 | 0.84 | CHEK1 (0.40) | KDM1ACHEK1CYP19A1ARCYP11B2 | |
| SCHEMBL19913144 | 0.83 | KIF11 (0.39) | KIF11KDM1ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | CYNORA GMBH (DE) | 2022-12-08 | — | — | US | disclosed |
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200136054-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, OGFR, OR51E2 | KIF11 4417/4885KDM1A 2543/4885CHEK1 3808/4885 |
| US-20220388960-A1 | ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES | ALDH1A2, AOX1, CYBA | KIF11 3588/4885KDM1A 3491/4885CHEK1 1237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.